|
Diabetes Drug May Slow Parkinson's Disease - Medscape
https://www.neurotalk.org//t3.gstati...kFbQDb8VKnLvkh
Medscape <img alt="" height="1" width="1"> Diabetes Drug May Slow Parkinson's Disease Medscape The type 2 diabetes drug exenatide (Bydureon, Byetta, AstraZeneca) has potential disease-modifying effects in Parkinson's disease, results of a randomized, double-blind, placebo-controlled trial suggest. Study results show the glucagon-like peptide-1 ... More... |
| All times are GMT -5. The time now is 11:46 AM. |
Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.